Literature DB >> 8251652

Paracrine interaction in co-culture of hormone-dependent and independent breast cancer cells.

V Cappelletti1, C Ruedl, P Miodini, L Fioravanti, D Coradini, G Di Fronzo, R Silvestrini.   

Abstract

A permeable solid support (Transwell Coll.) was used to develop serum-free co-cultures allowing paracrine interactions between hormone-dependent (MCF-7, ZR75.1) and hormone-independent (MDAMB-231, BT20) breast cancer cell lines. Both hormone-independent cell lines were able to stimulate the growth of the hormone-dependent lines, whereas the opposite was observed only in the case of BT20 co-culture with ZR75.1 cells. The cell growth stimulation observed in co-cultures could be abolished by the addition to the culture medium of an excess of transforming growth factor alpha (TGF alpha) or insulin-like growth factor I (IGF-I). Similarly, treatment with a neutralizing anti TGF alpha antibody impaired the growth stimulation exerted by hormone-independent cells on hormone-dependent cells. These results confirm the important role of paracrine interactions in control of the growth of human heterogeneous breast tumors and suggest that the main growth factors involved in such interactions are TGF alpha and probably some growth factors from the insulin-like growth factor family rather than IGF-I itself.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251652     DOI: 10.1007/bf00665805

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  24 in total

1.  The paracrine stimulation of MCF-7 cells by MDA-MB-231 cells: possible role in antiestrogen failure.

Authors:  S P Robinson; V C Jordan
Journal:  Eur J Cancer Clin Oncol       Date:  1989-03

2.  Growth stimulation of human breast epithelial cells by basic fibroblast growth factor in serum-free medium.

Authors:  K Takahashi; K Suzuki; S Kawahara; T Ono
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

Review 3.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

4.  Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.

Authors:  S R Ahmed; B Badger; C Wright; A Manni
Journal:  J Steroid Biochem Mol Biol       Date:  1991-06       Impact factor: 4.292

5.  Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Authors:  C L Arteaga; L J Kitten; E B Coronado; S Jacobs; F C Kull; D C Allred; C K Osborne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

Review 6.  Insulin-like growth factor expression in breast cancer epithelium and stroma.

Authors:  K J Cullen; A Allison; I Martire; M Ellis; C Singer
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Expression of IGF-I and IGF-II mRNA in breast tissue.

Authors:  S Paik
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Interaction between hormone-dependent and hormone-independent human breast cancer cells.

Authors:  V Cappelletti; C Ruedl; G Granata; D Coradini; G Del Bino; G Di Fronzo
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

9.  Stromal influences on breast cancer cell growth.

Authors:  C E van Roozendaal; B van Ooijen; J G Klijn; C Claassen; A M Eggermont; S C Henzen-Logmans; J A Foekens
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

10.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Authors:  A Borg; H Sigurdsson; G M Clark; M Fernö; S A Fuqua; H Olsson; D Killander; W L McGurie
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

View more
  1 in total

1.  The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function.

Authors:  P Miodini; L Fioravanti; G Di Fronzo; V Cappelletti
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.